Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Do

Showing results (371-380 of 546) with videos related to

Pageof 55
Sort By:
Journal of Ophthalmic Inflammation and Infection|July 21, 2019
Effect of vitreomacular adhesion on the treatment outcomes in the STOP-Uveitis clinical trial for non-infectious uveitisMuhammad Hassan, Nam V Nguyen, Muhammad Sohail Halim, et al.
Ophthalmology|November 2, 2015
Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) StudyMohammad Ali Sadiq, Mohamed Kamel Soliman, Salman Sarwar, et al.
Scientific Reports|June 18, 2021
ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured corneaThang L Pham, Jiucheng He, Azucena H Kakazu, et al.
Physical Chemistry Chemical Physics : PCCP|March 5, 2020
New insights on the energy transfer mechanisms of Eu-doped CdS quantum dotsP M Tan, N X Ca, N T Hien, et al.
Diabetology & Metabolic Syndrome|September 28, 2019
Interaction of <i>HSD11B1</i> and <i>H6PD</i> polymorphisms in subjects with type 2 diabetes are protective factors against obesity: a cross-sectional studyMarcio F Chedid, Filipe V do Nascimento, Fernanda S de Oliveira, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
Ophthalmology|October 7, 2016
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) StudyYasir J Sepah, Mohammad Ali Sadiq, David Boyer, et al.
Clinical & Experimental Ophthalmology|April 3, 2019
New therapies in development for the management of non-infectious uveitis: A reviewMuhammad Hassan, Samendra Karkhur, Jeong H Bae, et al.
Eye (London, England)|April 15, 2024
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapyYasir Jamal Sepah, Diana V Do, Marina Mesquida, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Sentinel Lymph Node Biopsy Utilization and Positivity in Veterans with Cutaneous Melanoma: A Comparative Analysis of the VA Cancer Registry and the SEER ProgramDaniel Y Kim, Susan M Swetter, Linden Huhmann, et al.
Pageof 55

Showing results (371-380 of 546) with videos related to

Sort By:
Pageof 55
Journal of Ophthalmic Inflammation and Infection|July 21, 2019
Effect of vitreomacular adhesion on the treatment outcomes in the STOP-Uveitis clinical trial for non-infectious uveitisMuhammad Hassan, Nam V Nguyen, Muhammad Sohail Halim, et al.
Ophthalmology|November 2, 2015
Effect of Vitreomacular Adhesion on Treatment Outcomes in the Ranibizumab for Edema of the Macula in Diabetes (READ-3) StudyMohammad Ali Sadiq, Mohamed Kamel Soliman, Salman Sarwar, et al.
Scientific Reports|June 18, 2021
ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured corneaThang L Pham, Jiucheng He, Azucena H Kakazu, et al.
Physical Chemistry Chemical Physics : PCCP|March 5, 2020
New insights on the energy transfer mechanisms of Eu-doped CdS quantum dotsP M Tan, N X Ca, N T Hien, et al.
Diabetology & Metabolic Syndrome|September 28, 2019
Interaction of <i>HSD11B1</i> and <i>H6PD</i> polymorphisms in subjects with type 2 diabetes are protective factors against obesity: a cross-sectional studyMarcio F Chedid, Filipe V do Nascimento, Fernanda S de Oliveira, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
Ophthalmology|October 7, 2016
Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) StudyYasir J Sepah, Mohammad Ali Sadiq, David Boyer, et al.
Clinical & Experimental Ophthalmology|April 3, 2019
New therapies in development for the management of non-infectious uveitis: A reviewMuhammad Hassan, Samendra Karkhur, Jeong H Bae, et al.
Eye (London, England)|April 15, 2024
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapyYasir Jamal Sepah, Diana V Do, Marina Mesquida, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Sentinel Lymph Node Biopsy Utilization and Positivity in Veterans with Cutaneous Melanoma: A Comparative Analysis of the VA Cancer Registry and the SEER ProgramDaniel Y Kim, Susan M Swetter, Linden Huhmann, et al.
Pageof 55